Home › Calculator › IVBXF Dividend Calculator 2026
IVBXF Dividend Calculator 2026
No dividendHealthcareInnovent Biologics, Inc. · OTC
Price: $11.55 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
IVBXF is not a dividend-focused stock
IVBXF pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
IVBXF Dividend Yield
Innovent Biologics, Inc. (IVBXF) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When IVBXF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Innovent Biologics, Inc. (IVBXF) — Dividend Analysis 2026
Innovent Biologics, Inc. is a biopharmaceutical firm headquartered in Suzhou, People's Republic of China, established in 2011. It specializes in the discovery, advancement, and production of antibody-based drug candidates, with a strategic focus on therapeutic areas including cancer treatment (oncology), eye conditions (ophthalmology), immune system disorders (immunology), and metabolic ailments. Innovent's flagship therapeutic offering is Tyvyt (sintilimab), an anti-PD-1 monoclonal antibody utilized in managing various cancers, including Hodgkin's lymphoma and esophageal carcinoma. Additionally, its portfolio includes several other approved treatments: Byvasda, for diverse malignant tumors; Halpryza, addressing non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and Wegener's granulomatosis; Pemazyre, indicated for adults with advanced or metastatic cholangiocarcinoma; Olverembatinib, developed for adult patients requiring tyrosine kinase inhibitor treatment; and Cyramza, which targets four distinct cancer types. Beyond its commercialized products, Innovent maintains a robust pipeline of investigational therapies. These include IBI-301, a rituximab biosimilar for non-Hodgkin's lymphoma; IBI-302, a bispecific antibody fusion protein aimed at ocular fundus disease; IBI-306, a human monoclonal antibody designed to combat hypercholesterolemia; and IBI-310, a recombinant human anti-CTLA-4 monoclonal antibody being explored for liver cancer and renal cell carcinoma. The company is also advancing IBI-188, an anti-CD47 monoclonal antibody for advanced hematological and solid tumors; IBI-326, a fully human BCMA-CAR T-cell therapy targeting relapsed or refractory multiple myeloma in adults; IBI-376, for recurrent or refractory follicular lymphoma; and IBI-112, designated for psoriasis. Moreover, Innovent provides pharmaceutical product distribution services, alongside offering expert consultation and engaging in research and development activities. Its operational strategy is further bolstered by strategic alliances with partners such as NeoCura Bio-Medical Technology Co. Ltd., Roche Group, Ascentage Pharma Group International, Eli Lilly and Company, and Bolt Biotherapeutics, Inc.
IVBXF Dividend & DRIP — Frequently Asked Questions
Does IVBXF pay a dividend?
No. Innovent Biologics, Inc. (IVBXF) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of IVBXF?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does IVBXF have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. IVBXF has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to IVBXF
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full IVBXF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IVBXF position with:
🌍 IVBXF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold IVBXF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 IVBXF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 IVBXF Dividend Payment Schedule
IVBXF pays quarterly — 4 times per year. Ex-div: —.
📊 IVBXF vs Healthcare Benchmarks
How IVBXF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IVBXF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ IVBXF Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare IVBXF with peers: IVBXF vs ALPMF · IVBXF vs ALPMY · IVBXF vs BMXXY
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IVBXF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Innovent Biologics, Inc. (IVBXF) is currently trading at $11.55, 23% below its 52-week high. It does not currently pay a regular dividend.
Does IVBXF Pay a Dividend? Innovent Biologics, Inc. Dividend Status
Innovent Biologics, Inc. (IVBXF) is a healthcare stock trading at $11.55. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest IVBXF News
LiveProjected your IVBXF DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.